Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR - Wikidata - awgldk - TriplyDB

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR

http://www.wikidata.org/entity/Q36555952

about

The Role of Imaging in Aortic Valve Disease Normal values for cardiovascular magnetic resonance in adults and children Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping Detection of elevated right ventricular extracellular volume in pulmonary hypertension using Accelerated and Navigator-Gated Look-Locker Imaging for Cardiac T1 Estimation (ANGIE) cardiovascular magnetic resonance.Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance Assessing skeletal muscle mass: historical overview and state of the art Review of Journal of Cardiovascular Magnetic Resonance 2012.Review of Journal of Cardiovascular Magnetic Resonance 2013 A case report in cardiovascular magnetic resonance: the contrast agent matters in amyloid.Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study.Post-contrast myocardial T(1) and ECV disagree in a longitudinal canine study.Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE.T1 mapping and survival in systemic light-chain amyloidosis.Single bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla.The association between cardiovascular risk and cardiovascular magnetic resonance measures of fibrosis: the Multi-Ethnic Study of Atherosclerosis (MESA)Cardiovascular magnetic resonance for amyloidosis.Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis.Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass.Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage.Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis.Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure.Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission.Myocardial T1 mapping: modalities and clinical applications.Cardiac MRI: a central prognostic tool in myocardial fibrosis.T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance.Advances in cardiac magnetic resonance imaging of congenital heart disease.Kinetic index combining native and postcontrast myocardial T1 in hypertrophic cardiomyopathy.PET/MR: Yet another Tesla?Redefining the role of biomarkers in heart failure trials: expert consensus document.Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications.Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.Assessment of Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance T1 Mapping: Correlation with Left-Ventricular Diastolic Dysfunction and Diabetic Duration.Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects.Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial Expansion in Hypertrophic Cardiomyopathy.

P2860

Q26744817-54C91B57-5F8B-46D3-BB0C-B4A174606FE6 Q26998833-49D08DF2-7ADF-406B-B72D-06139A0C4563 Q27025677-70837B51-4349-4276-9931-50DC2E737C3B Q30277881-3EC8AE6D-38E5-49EE-8B9E-AC37BE2FF5AC Q30423465-451AB159-77B7-4FE1-A89E-3613BC87BD74 Q30441307-0234AFB5-6B4A-4A02-9C5E-8A98E89048D8 Q30446298-86805DB9-3EE7-463B-8AAD-274F011C46E4 Q30487473-CA131896-BAA9-4C2C-80D4-E4F033BD44E2 Q30834174-9B1BFBAF-9D13-40B2-A581-C0FA95239950 Q33585317-DF49D4FA-2138-49C1-89B7-447C90C81800 Q34488328-44DA5022-F013-4A9D-AFBE-F4B9436D663B Q34681124-4AF947A6-7503-4F91-9C13-D80F639D35D2 Q34994098-9CC1634F-3DC3-47D7-8501-52ECEA45AA5C Q35030258-812C9CDB-87BC-4ABA-A95B-A91A8116EB4D Q35079303-CCEA5B1B-6D22-4C75-A779-D1F0DD703981 Q35535955-BF6AB369-AC2C-4810-8EB5-EEACADB3F4E0 Q36165179-15F17004-AADA-4CE2-8F9F-F960D7E96C9D Q36220925-A8AB38FD-DDA9-4F36-89C8-136765CFF932 Q36256825-2851319B-1831-450F-9EB2-B0313B53DA27 Q36489696-9E96004A-0CC2-4614-83C6-498DBCE4962E Q36836362-1DF0C10A-29DB-4859-8342-720979989EEB Q36942199-19A9201F-7462-45D9-BE9B-3B53C2D9AD21 Q37070852-F5A039E0-3486-4331-ADF2-A9C4A5265406 Q37371632-8386C6D4-79C7-42BC-A2F6-B04786E8D7D6 Q37438268-F76B1DA3-F210-4BEB-ACA0-DA10BDD1E751 Q37623441-3127C2AB-B423-41E9-9DE6-6F61A42CF3E9 Q37717684-C8494A69-D16C-4930-9AD2-981DDE935363 Q38263089-A5F58D6F-A870-4BAE-BFBB-5BA89B2FABAC Q38270769-A9D2CD8C-60E8-4F00-A589-C7DA48993B05 Q38304851-79EDEAD7-6EA7-4151-81A2-57958FB1EB04 Q38484413-FD1A3107-AB09-4DC8-83A7-311767987DE8 Q38818563-C8540B00-3BC3-4359-B12E-C75CA4B2662A Q39195160-A6B55074-0339-4E5D-A8DA-16656C4A3123 Q39370604-3AF4909E-BB9B-4332-8542-9673E3798BFD Q39392998-4D47A7B2-B78D-470F-83A4-A60E8D538D5D Q41169113-CB9C8241-6D2A-448F-B9BB-3D2830358D64 Q42089705-FEC40B74-5132-4B9A-991A-8448573822CD Q42365793-E30102B2-EFF1-4931-A01F-8F5801FBB0C1 Q42373017-E19AC02A-760E-46B3-9DD2-49400CADF69C Q42380710-38BC1171-AD50-4548-BF2F-C83F9F9C84CC

P2860

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR

http://www.wikidata.org/entity/Q36555952

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Comparison of T1 mapping techn ...... ation equilibrium contrast CMR

@ast

Comparison of T1 mapping techn ...... ation equilibrium contrast CMR

@en

type

label

Comparison of T1 mapping techn ...... ation equilibrium contrast CMR

@ast

Comparison of T1 mapping techn ...... ation equilibrium contrast CMR

@en

prefLabel

Comparison of T1 mapping techn ...... ation equilibrium contrast CMR

@ast

Comparison of T1 mapping techn ...... ation equilibrium contrast CMR

@en

P1433

Q36555952-3C6D4F20-5549-4655-8B38-A7956255EFC3

P1476

Q36555952-1612A819-8472-4256-BE91-0570B26E39BE

P2093

Q36555952-1488C357-B172-4A1C-AE26-CD0DEC99FB45

Q36555952-3263BA66-7A19-4196-BAA8-43773CDA0D4F

Q36555952-54ED026B-66DB-4673-BB31-B642FB3449EF

Q36555952-627242A1-DEDB-402A-83BF-58E3B6596980

Q36555952-69278443-F294-47A8-8D06-A37FCC3C7416

Q36555952-D8AE6336-31DB-4A40-8A9A-57FBCA7F589A

P2860

Q36555952-0594CA0E-EFC7-4EA2-BF0B-B6FD16156CF7

Q36555952-06136D22-A25F-4CFA-8BAA-C49B38928091

Q36555952-20F5234D-111F-4EFF-810D-EFD8503D5C94

Q36555952-21A5DC79-3322-4099-9DA4-F7E8B7ED7F95

Q36555952-2B59AA79-1AFD-42DB-87D1-345D0F1C8E37

Q36555952-34E6A783-D239-412B-B3F2-033939017612

Q36555952-8E832B5E-CA3A-4DDD-8978-B401D482D4E2

Q36555952-9DAA7CB2-407E-405A-A1D5-89856912B710

Q36555952-B01A4A68-1127-4F30-8BBE-7BF30FCD00F1

Q36555952-B7A546C4-9ECD-4745-8FDF-850EA0969B3C

P2888

Q36555952-B8BC6643-4161-46B1-9C16-ABA0DBB194CA

P304

Q36555952-317345EE-3DA6-40B6-9160-E4E509AB9952

P31

Q36555952-9986C1BC-BD62-47C5-BCEE-B125A63F0F61

P356

Q36555952-9025A953-B59F-4EC6-9F62-40106B586EAF

P478

Q36555952-0263A32F-8470-4FD4-86A7-8091AD503894

P50

Q36555952-12A4754E-C195-4AD0-9875-1083F3FD6488

Q36555952-464BB706-93C8-48F3-BFA2-89B60797B64D

Q36555952-F361FA11-42D0-4984-B401-BACF697C4B6B

Q36555952-F99A5775-4CD3-4B16-8BB3-29910AC18F0D

P577

Q36555952-B9EF4CCF-7A31-4AB8-9FE4-4D2E8E0797F4

P6179

Q36555952-74F26009-A36C-4C3A-83BF-B18DAC7A9A58

P698

Q36555952-9F7CED3E-5CED-472F-BEA8-19686BDB21FF

P921

Q36555952-672F0445-8754-437C-AD83-B02A4F7EEB79

P932

Q36555952-279541F5-0BB0-4BDA-9158-0BED8EDE1634

P356

1532-429X-14-88

P1433

Journal of Cardiovascular Magnetic Resonance

P1476

Comparison of T1 mapping techn ...... ation equilibrium contrast CMR

@en

P2093

Andrew S Flett

http://www.w3.org/2001/XMLSchema#string

Daniel M Sado

http://www.w3.org/2001/XMLSchema#string

Marianna Fontana

http://www.w3.org/2001/XMLSchema#string

Neil Roberts

http://www.w3.org/2001/XMLSchema#string

Sanjay M Banypersad

http://www.w3.org/2001/XMLSchema#string

Steve K White

http://www.w3.org/2001/XMLSchema#string

P2860

An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging.

Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart.

Motion correction for myocardial T1 mapping using image registration with synthetic image estimation.

Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold

Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus.

Myocardial T1 and extracellular volume fraction mapping at 3 tesla.

Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.

T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.

Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy

P2888

1532-429x-14-88

P304

88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1532-429X-14-88

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Stefan K. Piechnik

Viviana Maestrini

Stefan Neubauer

P577

2012-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1022796827

http://www.w3.org/2001/XMLSchema#string

P698

23272651

http://www.w3.org/2001/XMLSchema#string

P921

reproducibility

P932

3552758

http://www.w3.org/2001/XMLSchema#string